| | Start date | Site | Title | Topic |
|---|
| ML23270A956 | 29 September 2023 | | Full Materials License Signature Authority for Laura B. Cender for All Categories of Materials Licenses Including But Not Limited to: Broad Scope Use (Academic, Research and Development, Veterinary and In-Vitro - Testing, Nuclear Pharmacies | License Renewal
Brachytherapy |
| ML23198A203 | 20 July 2023 | | Public Meeting on Information Request-Draft Regulatory Guide 8061, July 20, 2023 | |
| ENS 56626 | 7 July 2023 05:00:00 | 3D Imaging Drug Design Development | Lost Package | Moisture Density Gauge |
| ML21230A318 | 30 April 2023 | | DG 8061 (RG 8.39 Rev 2) Release of Patients Administered Radioactive Material | Brachytherapy
Eye plaque |
| ML21341B436 | 15 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout | Brachytherapy
Stolen
Eye plaque |
| ML21326A168 | 22 November 2021 | | Draft Revision 2 of Regulatory Guide 8.39, Release of Patients Administered Radioactive Material, for ACMUI Review | Eye plaque |
| ENS 55543 | 25 October 2021 14:45:00 | Sofie | Agreement State - Contaminated Package | |
| ENS 55465 | 16 June 2021 05:00:00 | 3D Imaging Drug Design Development | Missing Radioactive Shipment | Moisture Density Gauge |
| ML22161A961 | 30 April 2020 | 07109228 | GE-Hitachi Nuclear Energy Americas, LLC - Model 2000 Radioactive Material Transport Package Safety Analysis Report | Hydrostatic
Nondestructive Examination
Finite Element Analysis
Fuel cladding
Liquid penetrant |
| ML20056E123 | 11 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 11, 2020 Meeting Ebinder | Brachytherapy |
| ML20056D981 | 31 December 2019 | | Draft Final Proposed Regulatory Guide 8.39, Release of Patients Administered Radioactive Materials, Revision 1 (Phase 1) for ACMUI Review | Brachytherapy |
| ML19108A463 | 31 July 2019 | | Draft Regulatory Guide (DG)-8057, Release of Patients Administered Radioactive Material | Brachytherapy |
| ML19143A404 | 10 June 2019 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) June 10, 2019 Meeting Ebinder | Incorporated by reference
Brachytherapy |
| ML19157A111 | 6 June 2019 | | Preliminary Draft Proposed Regulatory Guide 8.39, Release of Patients Administered Radioactive Materials, Revision 1 (Phase 1) for ACMUI Review with Note | Incorporated by reference
Brachytherapy |
| ENS 52695 | 19 April 2017 04:00:00 | Zevacor Pharma Inc. | Agreement State Report - Contaminated Package | |
| PLA-7131, Calculation Number EC-RADN-1129, Revision 4, DBA-LOCA Total Control Room Dose. | 10 January 2014 | Susquehanna | Calculation Number EC-RADN-1129, Revision 4, DBA-LOCA Total Control Room Dose. | |
| ML082421138 | 7 July 2008 | Susquehanna | Nuclear Engineering Calculation EC-RADN-1129, Revision 2, DBA-LOCA Total Control Room Dose | |
| ML060120429 | 6 September 2005 | Susquehanna | Calculation EC-RADN-1129, DBA-LOCA Total Control Room Dose. | |
| ML120040184 | 30 June 2004 | Indian Point | New York State (NYS) Pre-Filed Evidentiary Hearing Exhibit NYS000244, MACCS2 Computer Code Application Guidance for Documented Safety Analysis, Final Report (DOE-EH-4.2.1.4-MACCS2-Code Guidance) (June 2004) (MACCS2 Application Guidance) | Probabilistic Risk Assessment
Deep Dose Equivalent
Fatality |
| ML12335A643 | 30 June 2004 | Indian Point | Official Exhibit - NYS000244-00-BD01 - MACCS2 Computer Code Application Guidance for Documented Safety Analysis, Final Report (DOE-EH-4.2.1.4-MACCS2-Code Guidance) (June 2004) (MACCS2 Application Guidance) | Probabilistic Risk Assessment
Deep Dose Equivalent
Fatality |